Summary
From 1 January 1986 to 1 January 1988, 91 consecutive patients who had undergone repeated paravariceal endoscopic injection sclerotherapy (PEIS) for bleeding esophageal varices over a period of up to 10 years were followed up prospectively by endoscopy, manaometry and 24-h pH monitoring. In 39% nonfatal complications occurred after two phases of PEIS. The number of complications tended to decrease with increasing phases and was only 12% after five or more phases of PEIS. Endoscopy is undoubtedly the most important method in the follow-up of these patients. Early and long-term complications are mostly diagnosed by direct view and thus can be managed or sometimes even prevented in the follow-up. No significant motility disorders were found. Only 12 patients showed significant gastroesophageal reflux. No correlation was found between the severity of reflux and the number of phases of PEIS. No correlation between clinical symptoms and changes in the manometric and pH metric results could be found. The effects and side effects of PEIS can be closely monitored by manometry and pH monitoring and therapy can be tailored accordingly. Our results suggest that PEIS is a superb method with a low complication rate, both short- and long-term. It has proven to be an effective long-term treatment of bleeding esophageal varices.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cohen LB, Simon C, Korsten MA, Scherl EJ, Skorniky J, Guelrud MB, Waye JD (1985) Esophageal motility and symptoms after endoscopic injection sclerotherapy. Dig Dis Sci 30: 29–32
De Meester TR, Wang CI, Wernly JA, Pellegrini CA, Little AG, Klementschitsch P, Bermudez G, Johnson LF, Skinner DB (1980) Technique, indications and clinical use of 24-hour esophageal pH-monitoring. J Thorac Cardiovasc Surg 79: 656–670
Dodd WJ, Rogan WJ, Stef JJ, Miller WD, Lydon SD, Arndorfer RC (1975) A rapid pull-through technique for measuring lower esophageal sphincter pressure. Gastroenterology 68: 437–441
Eckhardt VF, Grace MD, Kantrowitz PA (1976) Does lower esophageal incompetency contribute to esophageal variceal bleeding? Gastroenterology 71: 1985–1989
Feussner H, Ultsch B, Weiser HI (1986) Oesophagusfunktion nach Oesophagusvarizensklerosierungstherapie. Langenbecks Arch Chir 369: 79–81
Heil C, Mattes P, Loeprecht H (1980) Gastroesophageal reflux: an aetiological factor for bleeding in esophageal varices? Br J Surg 67: 467–470
Larson GM, Vandertoll DJ, Netscher DT, Polk Jr HC (1984) Esophageal motility: effects of injection sclerotherapy. Surgery 96: 703–710
McDougall BRD, Westaby D, Theodossi A, Dawson JL, Williams R (1982) Increased long-term survival in variceal hemorrhage using injection sclerotherapy. Lancet I: 124–127
Murray-Lyon IM, Ogle SJ, Johnson AG (1982) Changes in esophageal function after injection sclerotherapy. In: Westaby D, MacDougall BRD, Williams R (eds) Variceal bleeding. Pitman, London Melbourne Wellington, pp 176–183
Ogle SJ, Kirk CJC, Bailey RJ, Johnson AG, Williams R, Murray-Lyon IM (1978) Oesophageal function in cirrhotic patients undergoing injection sclerotherapy for oesophageal varices. Digestion 18: 178–185
Paquet KJ, Feussner H (1984) Spätergebnisse nach Wandsklerosierung der Speiseröhre wegen akuter oder rezidivierender Ösophagusvarizenblutung. Verdauungskrankheiten 2: 11–15
Paquet KJ, Feussner H (1985) Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophago-gastric varices. A prospective controlled randomized trial. Hepatology 5: 580–581
Paquet KJ, Oberhammer E (1978) Sclerotherapy of bleeding esophageal varices by means of endoscopy. Endoscopy 10: 7–12
Paquet KJ, Denck H, Zöckler CE (1984) Die Ösophagusvarizenblutung — Diagnose und Therapie. TM-Verlag, Hameln Bad Oeynhausen
Paquet KJ, Koussouris P, Feussner H (1986) Funktionelle Untersuchungen der terminalen Speiseröhre vor und nach mehrfacher Wandsklerosierung wegen Ösophagusvarizenblutung. In: Husemann H, Groitl H (eds) Der gastroösophageale Übergang. (Die Gastroenterologische Reihe, 22) Kali-Chemie, Hannover, pp 41–47
Paquet KJ, Kalk JF, Koussouris P (1988) Immediate endoscopic sclerosis of bleeding esophageal varices — a prospective evaluation over five years. Surg Endosc 2: 18–23
Reilly Jr JJ, Schade RR, Thiel DS van (1984) Esophageal function after injection sclerotherapy: pathogenesis of esophageal stricture. Am J Surg 147: 85–88
Sauerbruch T, Wirsching R, Leitner P, Weinzierl M, Pfahler M, Paumgartner G (1982) Esophageal function after sclerotherapy of bleeding varices. Scand J Gastroenterol 17: 745–751
Sauerbruch T, Wirsching R, Holl J, Gröbl J, Weinzierl M (1986) Effects of repeated injection sclerotherapy on acid gastroesophageal reflux. Gastrointest Endosc 32: 81–83
Schattenmann G, Weiser HF, Wielage T, Wildhirt E, Siewert JR (1982) Pathologischer gastroösophagealer Reflux als Ursache der Blutung aus Ösophagusvarizen? Z Gastroenterol 20: 544–546
Sivak MV (1984) Endoscopic sclerotherapy of esophageal varices. Praeger, New York Philadelphia Eastbourne
Snady H, Korsten MA (1986) Esophageal acid-clearance and motility after endoscopic sclerotherapy of esosphageal varices. Am J Gastroenterol 81: 419–422
Waldeck F, Jennewein HM, Siewert R (1973) The continuous withdrawal method for the quantitative analysis of the lower esophageal sphincter (LES) in humans. Eur J Clin Invest 3: 331–342
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Siemens, F., Paquet, K.J., Koussouris, P. et al. Long-term endoscopic injection sclerotherapy of bleeding esophageal varices. Surg Endosc 3, 137–141 (1989). https://doi.org/10.1007/BF00591359
Issue Date:
DOI: https://doi.org/10.1007/BF00591359